Application | Comment | Organism |
---|---|---|
drug development | introduction of substituents in the 3'-position may result in nucleoside analogues with increased resistance to dephosphorylation, design of drugs that are less prone to inactivation by the deoxyribonucleotidases | Homo sapiens |
drug development | introduction of substituents in the 3'-position may result in nucleoside analogues with increased resistance to dephosphorylation, design of drugs that are less prone to inactivation by the deoxyribonucleotidases | Mus musculus |
Cloned (Comment) | Organism |
---|---|
- |
Homo sapiens |
D12N mutant expressed in the Escherichia coli Rosetta strain | Mus musculus |
Crystallization (Comment) | Organism |
---|---|
by hanging drop vapor diffusion method, cdN in complex with 2'deoxyuridine 5'-phosphate to 1.2 A resolution, space group P1, mutant of mdN in complex with the nucleotide analogues 3'-azido-2',3'-dideoxythymidine 5'-phosphate to 1.8 A resolution, space group P43212, and in complex with (E)-5-(2-bromovinyl)-2'deoxyuridine 5'-phosphate to 1.95 A resolution, space group P432132 | Homo sapiens |
by hanging drop vapor diffusion method, D12N mutant in complex with 3'-dUMP to 1.9 A resolution, space group P62, and in complex with 3'-dGMP to 2.0 A resolution, space group P62 | Mus musculus |
Protein Variants | Comment | Organism |
---|---|---|
D12N | inactive | Mus musculus |
D41N | mutant of mdN, inactive | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
cytosol | - |
Homo sapiens | 5829 | - |
cytosol | - |
Mus musculus | 5829 | - |
mitochondrion | - |
Homo sapiens | 5739 | - |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mg2+ | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Mus musculus | Q9JM14 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
(E)-5-(2-bromovinyl)-2'-deoxyuridine 5'-phosphate + H2O | - |
Homo sapiens | (E)-5-(2-bromovinyl)-2'-deoxyuridine + phosphate | - |
? | |
2'-deoxyuridine 5'-phosphate + H2O | - |
Homo sapiens | 2'-deoxyuridine + phosphate | - |
? | |
3'-azido-2',3'-dideoxythymidine 5'-phosphate + H2O | - |
Homo sapiens | 3'-azido-2',3'-dideoxythymidine + phosphate | - |
? | |
3'-dGMP + H2O | - |
Mus musculus | 2'-deoxyguanosine + phosphate | - |
? | |
3'-dUMP + H2O | - |
Mus musculus | 2'-deoxyguanosine + phosphate | - |
? | |
additional information | cdN has higher activity for purine nucleotides than does mdN, active site residues Leu45 and Tyr65 in cdN form a more favorable binding surface for purine nucleotides than the corresponding Trp75 and Trp76 in mdN | Homo sapiens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
cdN | - |
Homo sapiens |
cdN | - |
Mus musculus |
mdN | - |
Homo sapiens |